To the editors, Olfactory Neuroblastomas (ONBs) are tumors of neuroectodermal origin which, according to World Health Organization, usually not express cytokeratin [1] . In their paper entitled ''Neuroendocrine Neoplasm of the Sinonasal Tract: Neuroendocrine Carcinomas and Olfactory Neuroblastoma'' Shah and Perez-Ordoñez [2] reported a cytokeratins positivity, observed in up to 30 % of ONBs, in accordance with other Authors who documented cytokeratins expression from 23 to 35 % of cases, both focal or diffuse with strongly intensity, but never showing a paranuclear or globoid stain (''dot-like'' pattern). This latter being an important difference respect to Neuroendocrine Carcinoma (NEC) [1] [2] [3] [4] [5] . Furthermore another recent article by Holbrook et al. [6] demonstrated that cytokeratin 18 (CK18) was positive in ONB separating tumor cells into nests.
We recently observed a small biopsy performed on a stenotic right nasal cavity in a 44 years old man. Histological examination revealed a submucosal infiltration of epithelial-like neoplasia, with nested pattern of growth and high vascularity (Fig. 1a) . The neoplastic cells had abundant cytoplasm and atypical nuclei with prominent nucleoli; the mitotic rate was low. Immunohistochemical staining showed diffuse and strong cytoplasmatic positivity for synaptophysin (Fig. 1b) and neuron specific enolase (NSE); the S-100 was positive in a sustentacular cell pattern (Fig. 1c) , while EMA, GFAP, and TTF-1 were negative. Moreover a patchy and strong positivity, with a ''dotlike'' pattern for multicytokeratin (Novocastra TM Liquid Mouse Monoclonal Antibody Cytokeratin-5/6/8/18, clone 5D3 and LP34, dilution 1:100, full automated immunohistochemistry stainer BOND-III Leica Biosystems) was observed (Fig. 1d) .
In order to better understanding the specificity of this immunoreactivity we decided to perform the separate immunostaining for CK 5 (Leica Biosystems, clone XM26, ready to use, BOND-III Leica Biosystems), CK 6 (Invitrogen TM , clone SP87, dilution 1:100, BOND-III Leica Biosystems), CK 8 (Leica Biosystems, clone TS1, ready to use, BOND-III Leica Biosystems), CK18 (Dako, clone DC10, dilution 1:15, BOND-III Leica Biosystems), multicytokeratin AE1/AE3 (Novocastra TM , cocktail of two clones AE1 and AE3, ready to use, BOND-III Leica Biosystems) and multicytokeratin 34bE12 (Novocastra TM , clone 34bE12, ready to use, BOND-III Leica Biosystems). CK5, CK6, multicytokeratin AE1/AE3 and 34bE12 were all negative. Instead the neoplasm showed CK18 positivity, focally dot-like (Fig. 1e) and, surprisingly, focally CK8 positivity too, never reported for ONB in Literature to our knowledge (Fig. 1f) . The CK18 immunostaining result was in accordance with the article of Holbrook et al. [6] . The morphological and immunophenotypical features were consistent with the diagnosis of ONB, but with an aberrant expression of cytokeratins.
In conclusion our case represents the first demonstration of a ''dot-like'' cytokeratin expression in an ONB, a feature hitherto undescribed to our knowledge and supplements the Literature data [2] [3] [4] [5] . Pathologists should be aware of this potential diagnostic pitfall in distinguishing a high grade ONB from a high grade NEC, particularly in scanty & Martina Mandarano mandaranomartina@gmail.com biopsies [2] , in which is crucial an integration of immunohistochemical data with careful interpretation of morphological features.
